DOW-ISONIAZID Drug Patent Profile
✉ Email this page to a colleague
When do Dow-isoniazid patents expire, and what generic alternatives are available?
Dow-isoniazid is a drug marketed by Dow Pharm and is included in one NDA.
The generic ingredient in DOW-ISONIAZID is isoniazid. There is one drug master file entry for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the isoniazid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dow-isoniazid
A generic version of DOW-ISONIAZID was approved as isoniazid by CMP PHARMA INC on November 10th, 1983.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DOW-ISONIAZID?
- What are the global sales for DOW-ISONIAZID?
- What is Average Wholesale Price for DOW-ISONIAZID?
Summary for DOW-ISONIAZID
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 116 |
| Clinical Trials: | 246 |
| Patent Applications: | 3,626 |
| DailyMed Link: | DOW-ISONIAZID at DailyMed |
Recent Clinical Trials for DOW-ISONIAZID
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Virginia | PHASE3 |
| National Institute of Allergy and Infectious Diseases (NIAID) | PHASE3 |
| Infectious Diseases Institute | PHASE2 |
US Patents and Regulatory Information for DOW-ISONIAZID
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dow Pharm | DOW-ISONIAZID | isoniazid | TABLET;ORAL | 080330-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
